Abstract:Background Current approaches fail to separate patients at high versus low risk for ventricular arrhythmias owing to overreliance on a snapshot left ventricular ejection fraction measure. We used statistical machine learning to identify important cardiac imaging and time‐varying risk predictors. Methods and Results Three hundred eighty‐two cardiomyopathy patients (left ventricular ejection fraction ≤35%) underwent cardiac magnetic resonance before primary prevention implantable cardioverter defibrillator insertion. The primary end point was appropriate implantable cardioverter defibrillator discharge or sudden death. Patient characteristics; serum biomarkers of inflammation, neurohormonal status, and injury; and cardiac magnetic resonance‐measured left ventricle and left atrial indices and myocardial scar burden were assessed at baseline. Time‐varying covariates comprised interval heart failure hospitalizations and left ventricular ejection fractions. A random forest statistical method for survival, longitudinal, and multivariable outcomes incorporating baseline and time‐varying variables was compared with (1) Seattle Heart Failure model scores and (2) random forest survival and Cox regression models incorporating baseline characteristics with and without imaging variables. Age averaged 57±13 years with 28% women, 66% white, 51% ischemic, and follow‐up time of 5.9±2.3 years. The primary end point (n=75) occurred at 3.3±2.4 years. Random forest statistical method for survival, longitudinal, and multivariable outcomes with baseline and time‐varying predictors had the highest area under the receiver operating curve, median 0.88 (95% CI, 0.75‐0.96). Top predictors comprised heart failure hospitalization, left ventricle scar, left ventricle and left atrial volumes, left atrial function, and interleukin‐6 level; heart failure accounted for 67% of the variation explained by the prediction, imaging 27%, and interleukin‐6 2%. Serial left ventricular ejection fraction was not a significant predictor. Conclusions Hospitalization for heart failure and baseline cardiac metrics substantially improve ventricular arrhythmic risk prediction. Nonstandard Abbreviations and Acronyms LGE late gadolinium enhancement RF‐SLAM random forest survival, longitudinal and multivariate outcomes SCD sudden cardiac death SI signal intensity Clinical Perspective What Is New? In primary prevention implanted cardioverter defibrillator (ICD) recipients, an interim hospitalization for heart failure identified a group at high risk for subsequent ventricular arrhythmia defined as an appropriate ICD shock. Among ICD recipients without heart failure hospitalizations, baseline cardiac magnetic resonance imaging metrics (specifically, left ventricle heterogeneous gray and total scar, left ventricle and left atrial volumes, and left atrial total emptying fraction) as well as serum interleukin‐6 levels were the strongest predictors of subsequent appropriate ICD shock; serial left ventricle ejection fraction did not provide additional prognostic value for the arrhythmic outcome. Machine learning statistical methods may improve risk score development by accounting for complex and dynamic interactions among risk variables and temporally varying risk. What Are the Clinical Implications? The combination of clinical heart failure course, baseline cardiac magnetic resonance imaging metrics, and levels of the inflammatory biomarker interleukin‐6 can most accurately stratify subsequent high versus low ventricular arrhythmic risk and may be useful for decision‐making as primary prevention ICD recipients approach elective generator change. Identifying patients most at risk for ventricular arrhythmias and sudden cardiac death (SCD) remains a clinical challenge. 1 Current guidelines directing the use of primary prevention implanted cardioverter defibrillator (ICDs) rely on a reduced left ventricular ejection fraction (LVEF), which has low predictive efficiency. 1 Estimated annualized rates of appropriat -Abstract Truncated-

Combining noninvasive risk stratification parameters improves the prediction of mortality and appropriate ICD shocks

Prophylactic ICD Survival Benefit Prediction: Review and Comparison between Main Scores

Risk Stratification in Idiopathic Dilated Cardiomyopathy Patients Using Cardiovascular Coupling Analysis

Implantable Cardioverter Defibrillators for Sudden Cardiac Death Prevention in China: A Regional Analysis from the Improve SCA Clinical Trial

Dynamic changes in cardiovascular and systemic parameters prior to sudden cardiac death in heart failure with reduced ejection fraction: a PARADIGM-HF analysis

Prognostic value of electrocardiographic time intervals and QT rate dependence in hypertrophic cardiomyopathy

Sudden Cardiac Death Prevention in Patients with Ischemic Heart Disease-Beyond the Ejection Fraction

Trans-Atlantic Differences in Approach to Sudden Death Prevention in Patients With Hypertrophic Cardiomyopathy

Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts

Effectiveness of contemporary risk stratification in patients with hypertrophic cardiomyopathy: a pilot study

Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy.

Risk prediction in post-infarction patients with moderately reduced left ventricular ejection fraction by combined assessment of the sympathetic and vagal cardiac autonomic nervous system

Microvolt T-wave alternans and autonomic nervous system parameters can be helpful in the identification of low-arrhythmic risk patients with ischemic left ventricular systolic dysfunction

Contribution of the 24 hour electrocardiogram to the prediction of sudden coronary death.

Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35

Predictors of appropriate ICD discharges and the additive role of late gadolinium enhancement in hypertrophic cardiomyopathy

Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy

Investigation of the relationship between two novel electrocardiogram-based sudden cardiac death risk markers and autonomic function

Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study